This resource is no longer available

Pandemics, shifting drug prices, government healthcare mandates, regulatory requirements, calls for consumer customization—challenges such as these have driven pharmaceutical & biopharma processors to look at ways to streamline operations and reduce costs to manufacture faster.

Watch this discussion on how the Virtual Twin of biomanufacturing processes and recipes, as well as the Virtual Twin of buildings, equipment and single-use kits, can help Life Sciences companies and CMOs to implement modular and flexible drug manufacturing and accelerate industrialization, scale-up and tech transfer, leading ultimately to more sustainable drug manufacturing.

Vendor:

Dassault Systemes

Premiered:

Nov 2, 2023

Format:

HTML

Type:

Webcast